在女性生殖器肿瘤中卵巢癌的发生率居第3位,但死亡率居首位。目前,晚期卵巢癌的治疗方法主要为细胞减灭术及术后化疗。研究表明,卵巢癌化疗可延长患者生存期,甚至较单纯手术延长6～7倍。因此化疗在卵巢癌中的价值已得到充分肯定。该癌一线化疗有效率(RR)能达到60%～80%,但是,其中仍有55%～75%的患者于治疗后1～2年内 The incidence of ovarian cancer in female genital tumors ranked No. 3, but the mortality rate ranks first. At present, the treatment of advanced ovarian cancer cytoreductive surgery and postoperative chemotherapy. Studies have shown that ovarian cancer chemotherapy can extend the survival of patients, even more than simple surgery to extend 6 to 7 times. Therefore, the value of chemotherapy in ovarian cancer has been fully affirmed. The first-line chemotherapy of the cancer rate (RR) can reach 60% to 80%, however, of which 55% to 75% of patients still within 1 to 2 years after treatment